M. Gaubitz

3.0k total citations
72 papers, 1.7k citations indexed

About

M. Gaubitz is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, M. Gaubitz has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Rheumatology, 17 papers in Immunology and 15 papers in Hematology. Recurrent topics in M. Gaubitz's work include Systemic Lupus Erythematosus Research (29 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). M. Gaubitz is often cited by papers focused on Systemic Lupus Erythematosus Research (29 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). M. Gaubitz collaborates with scholars based in Germany, Belgium and France. M. Gaubitz's co-authors include Bettina Pfleiderer, Gereon Heuft, Markus Burgmer, Wolfram Domschke, P. Willeke, Esther Pogatzki‐Zahn, Heiko Schotte, H. Becker, Carsten Konrad and Joseph Wajdula and has published in prestigious journals such as PLoS ONE, NeuroImage and Annals of the New York Academy of Sciences.

In The Last Decade

M. Gaubitz

69 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. Gaubitz 730 363 355 334 266 72 1.7k
Neil Basu 1.0k 1.4× 373 1.0× 337 0.9× 156 0.5× 411 1.5× 100 2.4k
Kristine Phillips 507 0.7× 336 0.9× 329 0.9× 386 1.2× 364 1.4× 34 1.7k
Uzma Haque 469 0.6× 145 0.4× 245 0.7× 259 0.8× 218 0.8× 29 1.5k
Geoff Littlejohn 317 0.4× 350 1.0× 122 0.3× 286 0.9× 148 0.6× 25 977
Itzhak Rosner 839 1.1× 260 0.7× 620 1.7× 131 0.4× 165 0.6× 135 2.7k
Aki Hietaharju 849 1.2× 138 0.4× 372 1.0× 78 0.2× 325 1.2× 47 1.9k
Ayşegül Jale Saraç 298 0.4× 278 0.8× 99 0.3× 243 0.7× 119 0.4× 32 1.3k
Yeşim Kirazlı 1.5k 2.1× 284 0.8× 672 1.9× 163 0.5× 152 0.6× 51 2.5k
M I Jayson 601 0.8× 197 0.5× 241 0.7× 523 1.6× 196 0.7× 71 2.3k
Niveditha Mohan 477 0.7× 103 0.3× 235 0.7× 162 0.5× 80 0.3× 15 1.0k

Countries citing papers authored by M. Gaubitz

Since Specialization
Citations

This map shows the geographic impact of M. Gaubitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gaubitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gaubitz more than expected).

Fields of papers citing papers by M. Gaubitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gaubitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gaubitz. The network helps show where M. Gaubitz may publish in the future.

Co-authorship network of co-authors of M. Gaubitz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gaubitz. A scholar is included among the top collaborators of M. Gaubitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gaubitz. M. Gaubitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sundermann, Benedikt, Markus Burgmer, Esther Pogatzki‐Zahn, et al.. (2014). Diagnostic Classification Based on Functional Connectivity in Chronic Pain. Academic Radiology. 21(3). 369–377. 27 indexed citations
2.
Gause, Angela, et al.. (2010). Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010). Zeitschrift für Rheumatologie. 69(4). 365–372. 3 indexed citations
4.
Manger, Bernhard, et al.. (2009). Empfehlungen zur Therapie mit Interleukin-1β-blockierenden Wirkstoffen. Zeitschrift für Rheumatologie. 68(9). 766–771. 4 indexed citations
5.
Burgmer, Markus, et al.. (2009). Decreased Gray Matter Volumes in the Cingulo-Frontal Cortex and the Amygdala in Patients With Fibromyalgia. Psychosomatic Medicine. 71(5). 566–573. 175 indexed citations
6.
Wick, R., et al.. (2008). Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224. Lara D. Veeken. 47(6). 855–859. 31 indexed citations
7.
Becker, H., P. Willeke, Heiko Schotte, Wolfram Domschke, & M. Gaubitz. (2008). Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis. Clinical Rheumatology. 27(10). 1307–1311. 14 indexed citations
8.
Combe, B., Ugo Fiocco, M. Gaubitz, et al.. (2007). Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients. Document Server@UHasselt (UHasselt). 2 indexed citations
9.
Willeke, P., Bernhard Schlüter, H. Becker, et al.. (2007). Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial. Arthritis Research & Therapy. 9(6). R115–R115. 44 indexed citations
10.
Willeke, P., M. Gaubitz, Heiko Schotte, et al.. (2007). Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome. Arthritis Research & Therapy. 9(2). R43–R43. 21 indexed citations
11.
Klareskog, Lars, M. Gaubitz, Vicente Rodríguez‐Valverde, et al.. (2006). A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases. 65(12). 1578–1584. 67 indexed citations
12.
Willeke, P., Dirk Domagk, Martin Floer, et al.. (2005). Ischaemic colitis mimicking inflammatory bowel disease in a young adult receiving oral anticoagulation. Scandinavian Journal of Gastroenterology. 40(7). 878–880.
13.
Konrad, Carsten, Juliane Vollmer‐Haase, M. Gaubitz, et al.. (2004). Fracture of the odontoid process complicating tardive dystonia. Movement Disorders. 19(8). 983–985. 6 indexed citations
14.
Böhm, Markus, M. Gaubitz, Thomas A. Luger, Dieter Metze, & Gisela Bonsmann. (2003). Topical Tacrolimus as a Therapeutic Adjunct in Patients with Cutaneous Lupus erythematosus. Dermatology. 207(4). 381–385. 30 indexed citations
15.
Gaubitz, M., et al.. (2003). Immunoadsorption in Systemic Lupus Erythematosus: Different Techniques and their Current Role in Medical Therapy. Therapeutic Apheresis and Dialysis. 7(2). 183–188. 15 indexed citations
16.
Schneider, Matthias, et al.. (2002). Development of an in vitro miniature model to simulate immunoadsorption in patients with systemic lupus erythematosus. Journal of Clinical Apheresis. 17(4). 183–189. 7 indexed citations
17.
Gaubitz, M. & W Domschke. (2000). Intestinale Vaskulitiden - eine diagnostisch-therapeutische Herausforderung. Zeitschrift für Gastroenterologie. 38(2). 181–192. 3 indexed citations
18.
Gaubitz, M., et al.. (1996). Ig-IMMUNOADSORPTION IN A PATIENT WITH SLE : CHYLEOUS ASCITES AND CYTOPENIA. 15. 1 indexed citations
19.
Gaubitz, M., et al.. (1996). IMMUNOGLOBULINADSORPTION IN SLE : EXPERIENCES WITH 10 PATIENTS. 15. 1 indexed citations
20.
Diederich, Stefan, et al.. (1996). HRCT der Lunge bei Kollagenosen. Der Radiologe. 36(7). 567–578. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026